779
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Ultrasound microbubble-carried PNA targeting to c-myc mRNA inhibits the proliferation of rabbit iliac arterious smooth muscle cells and intimal hyperplasia

, , , , &
Pages 2482-2487 | Received 12 Oct 2014, Accepted 30 Jan 2015, Published online: 02 Mar 2015

References

  • An DJ, Jeong W, Jeoung HY, et al. (2012). Peptide nucleic acid-based (PNA) array for the antigenic discrimination of canine parvovirus. Res Vet Sci 93:515–19
  • Bai H, You Y, Yan H, et al. (2012). Antisense inhibition of gene expression and growth in gram-negative bacteria by cell-penetrating peptide conjugates of peptide nucleic acids targeted to rpoD gene. Biomaterials 33:659–67
  • Bonifazi D, Carloni LE, Corvaglia V, Delforge A. (2012). Peptide nucleic acids in materials science. Artif DNA PNA XNA 3:112–22
  • Choi YJ, Kim HS, Lee SH, et al. (2011). Evaluation of peptide nucleic acid array for the detection of hepatitis B virus mutations associated with antiviral resistance. Arch Virol 156:1517–24
  • Domenici F, Giliberti C, Bedini A, et al. (2013). Ultrasound well below the intensity threshold of cavitation can promote efficient uptake of small drug model molecules in fibroblast cells. Drug Deliv 20:285–95
  • Du YF, Wan MX, Zhao WM. (2001). Study on the preparation of a new sugar albumin microbubble ultrasound contrast agent. Acta Pharm Sinc 36:859–62
  • Erazo-Oliveras A, Muthukrishnan N, Baker R, et al. (2012). Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges. Pharmaceuticals 5:1177–209
  • Gambari R. (2014). Peptide nucleic acids: a review on recent patents and technology transfer. Expert Opin Ther Pat 24:267–94
  • Gong Y, Wang Z, Dong G, et al. (2014). Low-intensity focused ultrasound mediated localized drug delivery for liver tumors in rabbits. Drug Deliv. [Epub ahead of print]
  • Grijalvo S, Aviñó A, Eritja R. (2014). Oligonucleotide delivery: a patent review (2010–2013). Expert Opin Ther Pat 24:801–19
  • Heitz F, Morris MC, Divita G. (2009). Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol 157:195–206
  • Ji J, Ji S-Y, Yang J-A, et al. (2012). Ultrasound-targeted transfection of tissue-type plasminogen activator gene carried by albumin nanoparticles to dog myocardium to prevent thrombosis after heart mechanical valve replacement. Int J Nanomed 7:2911–19
  • Ji J, Lusheng S, Weihua F, Wenping L. (2001). Interferon-γ inhibits in situ expression of PDGF-β mRNA by smooth muscle cells in injured rabbit arteries after transluminal balloon angioplasty. China Med J 114:139–42
  • Kam Y, Rubinstein A, Nissan A, et al. (2012). Detection of endogenous K-ras mRNA in living cells at a single base resolution by a PNA molecular beacon. Mol Pharm 9:685–93
  • Khanna A. (2004). Concerted effect of transforming growth factor-beta, cyclin inhibitor p21, and c-myc on smooth muscle cell proliferation. Am J Physiol Heart Circ Physiol 286:H1133–40
  • Kusumanto YH, Mulder NH, Dam WA, et al. (2007). Improvement of in vivo transfer of plasmid DNA in muscle: comparison of electroporation versus ultrasound. Drug Deliv 14:273–7
  • Lamla M, Seliger H, Kaufmann D. (2010). Differences in uptake, localization, and processing of PNAs modified by COX VIII pre-sequence peptide and by triphenylphoshonium cation into mitochondria of tumor cells. Drug Deliv 17:263–71
  • Lao Y, Xiu JC. (2007). Progress of ultrasound microbubble contrast agent with gene and drug targeting therapy. J Med Imaging 17:1359–61
  • Lawrie A, Brisken AF, Francis SE, et al. (2000). Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther 7:2023–7
  • Lee RG, Crosby J, Baker BF, et al. (2013). Antisense technology: an emerging platform for cardiovascular disease therapeutics. J Cardiovasc Transl Res 6:969–80
  • Li X, He S, Gao Y, Zhang Y. (2007). Study for preparing specific targeted ultrasound contrast agent. Chinese J Ultrasound Med 23:493–5
  • Liang CY, Zhou DB, Yu XG, et al. (2007). Expression of c-myc mRNA on early restenosis after carotid endarterectomy. Zhonghua Wai Ke Za Zhi 45:555–7
  • Liao AH, Ma WC, Wang CH, Yeh MK. (2014). Penetration depth, concentration and efficiency of transdermal α-arbutin delivery after ultrasound treatment with albumin-shelled microbubbles in mice. Drug Deliv. [Epub ahead of print]
  • Ling ZY, Wang Z, Ran HT, et al. (2002). Experiment study on ultrasound-mediated microbubble destruction deliver VEGF gene to ischemic myocardium of rats. Chinese Ultrasound Med 18:502–4
  • Martin KH, Dayton PA. (2013). Current status and prospects for microbubbles in ultrasound theranostics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 5:329–45
  • Nielsen PE. (2010). Gene targeting and expression modulation by peptide nucleic acids (PNA). Curr Pharm Des 16:3118–23
  • Shiraishi T, Nielsen PE. (2011a). Enhanced cellular delivery of cell-penetrating peptide–peptide nucleic acid conjugates by photochemical internalization. Methods Mol Biol 683:391–7
  • Shiraishi T, Nielsen PE. (2011b). Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain. Methods Mol Biol 751:209–21
  • Sirsi SR, Borden MA. (2012). Advances in ultrasound mediated gene therapy using microbubble contrast agents. Theranostics 2:1208–22
  • Stender H, Williams B, Coull J. (2014). PNA fluorescent in situ hybridization (FISH) for rapid microbiology and cytogenetic analysis. Methods Mol Biol 1050:167–78
  • Sun RR, Noble ML, Sun SS, et al. (2014). Development of therapeutic microbubbles for enhancing ultrasound-mediated gene delivery. J Control Release 182:111–20
  • Wang J, Liu K, Shen L, et al. (2011). Small interfering RNA to c-myc inhibits vein graft restenosis in a rat vein graft model. J Surg Res 169:e85–91
  • Yuan QY, Huang J, Li XJ, et al. (2013). A transendocardial delivery and intracardiac ultrasound irradiation treatment catheter. Drug Deliv 20:252–7
  • Zhao YZ, Lu CT. (2007). Recent advances in the applications of ultrasonic microbubbles as gene delivery systems. Yao Xue Xue Bao 42:127–31

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.